Word

Status

Pending

Status Code

730

Status Date

Wednesday, December 13, 2023

Serial Number

97717477

Mark Type

2000

Filing Date

Wednesday, December 14, 2022

Published for Opposition

Tuesday, April 25, 2023

Trademark Owner History

Merck Sharp & Dohme LLC - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

The mark consists of identical hexagonal shapes, one solid and one light, reversed and interlocked, with shaded parallelogram in the middle.
Color is not claimed as a feature of the mark.

Trademark Events

Dec 15, 2023

Notice Of Approval Of Extension Request E-Mailed

Dec 13, 2023

Sou Extension 1 Granted

Dec 13, 2023

Sou Extension 1 Filed

Dec 13, 2023

Sou Teas Extension Received

Jun 20, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 25, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 25, 2023

Published For Opposition

Apr 5, 2023

Notification Of Notice Of Publication E-Mailed

Mar 21, 2023

Approved For Pub - Principal Register

Mar 21, 2023

Assigned To Examiner

Jan 12, 2023

Notice Of Design Search Code E-Mailed

Jan 11, 2023

New Application Office Supplied Data Entered

Dec 17, 2022

New Application Entered